Results 51 to 60 of about 1,317,105 (347)

Asiaticoside improves depressive-like behavior in mice with chronic unpredictable mild stress through modulation of the gut microbiota

open access: yesFrontiers in Pharmacology
BackgroundAsiaticoside, the main active ingredient of Centella asiatica, is a pentacyclic triterpenoid compound. Previous studies have suggested that asiaticoside possesses neuroprotective and anti-depressive properties, however, the mechanism of its ...
Qingyi Ren   +16 more
doaj   +1 more source

Neurological Disorders in Primary Sjögren's Syndrome. [PDF]

open access: yes, 2012
International audienceSjögren's syndrome is an autoimmune disease characterized by an autoimmune exocrinopathy involving mainly salivary and lacrimal glands.
Devauchelle-Pensec, Valérie   +3 more
core   +5 more sources

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez   +13 more
wiley   +1 more source

A Patient with Erdheim-Chester Disease Limited to Central Nervous System

open access: yesNeurology International, 2022
Erdheim-Chester disease (ECD) is a rare, sporadic, non-Langerhans cell histiocytosis, a multisystem disorder, which has higher mortality when presented with CNS involvement. We report a 46-year-old woman who has ECD with exclusive CNS involvement.
Rajesh K. Gupta   +3 more
doaj   +1 more source

Developmental Disorders in Children Recently Diagnosed With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Neurocognitive deficits in adult survivors of childhood cancer are well established, but less is known about developmental disorders (DD) arising shortly after cancer diagnosis. Using 2016–2019 linked Ohio cancer registry and Medicaid data, we compared DD among 324 children with cancer and 606,913 cancer‐free controls.
Jamie Shoag   +5 more
wiley   +1 more source

Cell-based therapeutic strategies for multiple sclerosis. [PDF]

open access: yes, 2017
The availability of multiple disease-modifying medications with regulatory approval to treat multiple sclerosis illustrates the substantial progress made in therapy of the disease.
Cohen, Jeffrey A   +6 more
core   +1 more source

Clinical Characteristics and Prognostic Risk Factors for Pediatric B‐Cell Lymphoblastic Lymphoma: A Multicenter Retrospective Cohort Study for China Net Childhood Lymphoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background B‐cell lymphoblastic lymphoma (B‐LBL) represents a rare variety of non‐Hodgkin lymphoma, with limited research on its biology, progression, and management. Methods A retrospective analysis was performed on the clinical characteristics of 256 patients aged ≤18 years who received treatment under the China Net Childhood Lymphoma (CNCL)‐
Zhijuan Liu   +20 more
wiley   +1 more source

Demyelinating Disease? Central Nervous System Lymphoma?

open access: yesTürk Nöroloji Dergisi, 2008
Scientific backgound: Primary lymphomas of the central nervous system (CNS) consist of about 1% of brain tumors. Primary central nervous system lymphoma (PSSSL) is a non-Hodgkin’s lymphoma restricted to the nervous system.
Ufuk Ergün   +6 more
doaj  

The Roles of Lpar1 in Central Nervous System Disorders and Diseases [PDF]

open access: gold, 2021
Dongqiong Xiao   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy